Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study
Mechanism of action for leflunomide in rheumatoid arthritis.
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Headwaters of the zebrafish -- emergence of a new model vertebrate.
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
CNS vasculitis in a patient with MS on daclizumab monotherapy.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Use of rituximab in multiple sclerosis: current progress and future perspectives.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Pattern of remyelination in the CNS.
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.

Pages